Belleau Labs
Back to companies

Sully.ai

Seed / Series A

defense-autonomy · Seed

Seed Signal Score
9/25
Team Strength
2/5
Validation Depth
2/5
Novelty
2/5
Market Timing
1/5
Capital Efficiency
2/5

Description

Autonomous team of AI agents that runs the entire hospital operations

Validation Signals

yc batch

Score Rationale

Sully.ai presents fundamental misalignment with defense-tech thesis: the company's core product (hospital operations automation) has no apparent connection to DoD priorities, and there is no evidence of military/defense domain expertise among founders or customers. YC batch acceptance alone (undated, likely 2021) provides minimal validation in a non-defense context, and the absence of SBIR awards, government contracts, or named defense pilots indicates this is a healthcare play miscategorized or repurposed post-hoc.
Back to all companies